Inaugural Meeting Agenda

Agenda of inaugural 2.3(c) Committee meeting: 2 December 2010, New Delhi

Agenda for New Delhi, India meeting of the 2.3(c)Committee

Conference Hall 2
India Islamic Cultural Centre
87-88, Lodhi Road
New Delhi -110 003
(Landmark – Near IIC Annexe)

Date: 2 December 2010

Expected Outcomes
1. Identify possible principles and objectives of the R&D Treaty
2. Begin to identify key areas of work
3. Begin work on a 1st draft of a road map for achieving our objectives, including a timeline, and the identification of key stakeholders and political actors whose support is important for moving forward

9:00 AM – 10:30 AM

Session 1: Setting the Context. 3 presentations to be followed by a Q&A
Why do we need an R&D Treaty? The long view (Michelle Childs, MSF)
The Kenya/Brazil resolution and its antecedents (James Love, KEI)
The R&D Treaty within the context of the WHO’s GSPA (German Velasquez, South Centre)
10:30 AM -10:45 AM


10:45 AM -12:30 PM

Session 2: What should be the guiding principles and objectives of an R&D Treaty? This will cover the following:
If we were to design a biomedical innovation system that ensured innovation and access to that innovation, what would it look like?
Should we focus on major changes in the current system, or take a more incremental approach, or consider both, with a path that connects the incremental to the larger reforms?
What aspects of the framework would require international cooperation?
Suggested leads: Carlos Correa (South Centre, To be confirmed), K. Gopakumar (TWN)

12:30-1:45 PM


1:45 PM – 3:-15 PM

Session 3: Norms- What possible norms could be discussed at a future 2.3c Committee meeting?
Sophie Bloemen (HAI)
Amit Sen Gupta (PHM)
John Amuasi (To be confirmed)
Tido von Schoen Angerer, MSF
3:15 PM – 3:30 PM


3:30 PM – 5:30 PM

Session 4: Developing a Road map for realizing the R&D Treaty
How do we make this tangible?
How will we achieve our objectives?
How do we build political support and buy in? Creating a target list for winning supporters at each stage
What is our timeframe for delivery on each aspect of this plan?
How will the 2.3c committee function?
Suggested facilitators: Pascale Boulet, Sophie Bloemen and Tido von Schoen Angerer (Interactive session)

5:30 PM – 6:00 PM

Session 5: Concluding remarks
Sophie Bloemen (HAI)
Michelle Childs (MSF)
K. Gopakumar (TWN)
James Love (KEI)
Amit Sen Gupta (PHM)
German Velasquez (South Centre)